z-logo
open-access-imgOpen Access
Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1.
Author(s) -
Michael Tiemeyer,
Stuart J. Swiedler,
Masayuki Imamura,
Margaret Moreland,
Hans Schweingruber,
Pam Hirtzer,
Brian K. Brandley
Publication year - 1991
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.88.4.1138
Subject(s) - glycolipid , biochemistry , chemistry , glycan , receptor , cell adhesion molecule , chondroitin sulfate , keratan sulfate , cell adhesion , asialoglycoprotein receptor , microbiology and biotechnology , biology , glycoprotein , glycosaminoglycan , in vitro , cell , hepatocyte
The acute inflammatory response requires that circulating leukocytes bind to and penetrate the vascular wall to access the site of injury. Several receptors have been implicated in this interaction, including a family of putative carbohydrate-binding proteins. We report here the identification of an endogenous carbohydrate ligand for one of these receptors, endothelial-leukocyte adhesion molecule 1 (ELAM-1). Radiolabeled COS cells transfected with a plasmid containing the cDNA for ELAM-1 were used as probes to screen glycolipids extracted from human leukocytes. COS cells transfected with this plasmid adhered to a subset of sialylated glycolipids resolved on TLC plates or adsorbed on polyvinyl chloride microtiter wells. Adhesion to these glycolipids required calcium but was not inhibited by heparin, chondroitin sulfate, keratan sulfate, or yeast phosphomannan. Monosaccharide composition, linkage analysis, and fast atom bombardment mass spectrometry of the glycolipids indicate that the ligands for ELAM-1 are terminally sialylated lactosylceramides with a variable number of N-acetyllactosamine repeats and at least one fucosylated N-acetylglucosamine residue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here